The Recall Desk
Agency classClass IOur severity:SevereFDA (Drugs)·D-0249-2022·Announced 2021-11-24

Lotrimin Daily Prevention Deo Tolnaftate Spray Recalled for Benzene Contamination

Bayer Healthcare Pharmaceuticals is recalling Lotrimin Daily Prevention Deo (Tolnaftate 1%) spray powder due to the presence of benzene contamination. The recall affects 579,456 cans distributed nationwide.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this as a Class I recall, which mandates a minimum severity score of 4 per the rubric. Benzene is a known carcinogen and toxic chemical with serious health implications when absorbed through skin or inhaled, warranting a Severe classification.

Plain-English summary

Bayer Healthcare Pharmaceuticals Inc. is recalling Lotrimin Daily Prevention Deo (Tolnaftate 1%) Daily Prevention deodorant powder spray due to chemical contamination—specifically the presence of benzene in the product.

The affected product is a topical antifungal spray sold in 160g (5.6 oz) aerosol cans. The recall involves 579,456 cans distributed nationwide in the United States, Puerto Rico, Canada, and Mexico through various retail channels. The recalled lots include Lot # TN0023D (expiration 2/28/2022) and Lot # TN004BX (expiration 6/30/2022), with UPC 0 41100 58720 6.

Consumers who have purchased this product should stop using it immediately and consult a healthcare provider if they have questions about their exposure. The product should not be used on the skin or inhaled.

The recalled product

Product
LOTRIMIN DAILY PREVENTION DEO (TOLNAFTATE)
Brand
LOTRIMIN DAILY PREVENTION DEO
Manufacturer
Bayer Healthcare Pharmaceuticals Inc.
Category
Drug — Topical antifungal spray
Hazard
Affected units
579,456

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot # TN0023D
  • EXP 2/28/2022
  • TN004BX
  • EXP 6/30/2022

UPCs (1)

  • 041100587206

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 19 recalled by Bayer Healthcare Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 19 products in this recall →

Related recalls

Same brand · LOTRIMIN DAILY PREVENTION DEO

Same manufacturer · Bayer Healthcare Pharmaceuticals Inc.

See all →

Same hazard · benzene contamination

See all →

Similar recalls